Air Canada and Transat stated they agreed to scuttle the proposed acquisition of Transat by Air Canada after European antitrust authorities indicated the deal wouldn’t receive their blessing, reported The Wall Street Journal.
The deal, disclosed in June 2019, was conditional on approval from various regulators. Canada’s Liberal government approved the transaction in February —even though Canada’s antitrust watchdog, the Competition Bureau, had serious reservations about the deal and its impact on competition.
Following recent discussions with the European Commission, Air Canada stated Friday, April 2, it was evident the commission “will not approve the acquisition based on the currently offered remedy package” to alleviate any competition concerns.
Air Canada also stated, “After careful consideration, Air Canada has concluded that providing additional, onerous remedies, which may still not secure commission approval, would significantly compromise Air Canada’s ability to compete internationally, negatively impacting customers, other stakeholders and future prospects as it recovers and rebuilds from the impact of the Covid-19 pandemic.”
Air Canada stated it would pay Transat a termination fee of CA$12.5 million (US$10 million).
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI